Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice

[1]  A. Ravindran,et al.  Contribution of sex hormones to gender differences in schizophrenia: A review. , 2015, Asian journal of psychiatry.

[2]  A. Gogos,et al.  Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats , 2015, Schizophrenia Research.

[3]  B. Dean,et al.  A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings , 2015, International journal of endocrinology.

[4]  R. Keefe,et al.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials , 2015, Molecular Psychiatry.

[5]  P. Schofield,et al.  Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia , 2015, Molecular Psychiatry.

[6]  R. Lenroot,et al.  Serum testosterone levels are related to cognitive function in men with schizophrenia , 2013, Psychoneuroendocrinology.

[7]  J. Isaacs,et al.  Of mice and men‐warning: Intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively , 2013, The Prostate.

[8]  N. Naghdi,et al.  Prepubertal castration causes the age‐dependent changes in hippocampal long‐term potentiation , 2013, Synapse.

[9]  P. Schofield,et al.  Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia , 2012, Molecular Psychiatry.

[10]  M. Solmi,et al.  Acute Psychotic Episode Associated with the Intake of a Testosterone-Enhancer Herbal Mixture Purchased Online , 2012, Psychotherapy and Psychosomatics.

[11]  P. Halley,et al.  Altered N-methyl-d-aspartate receptor function in reelin heterozygous mice: Male–female differences and comparison with dopaminergic activity , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Jayashri Kulkarni,et al.  Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review , 2012, Schizophrenia research and treatment.

[13]  C. Bondi,et al.  Glutamatergic animal models of schizophrenia. , 2012, Current pharmaceutical design.

[14]  Vidhi Singh,et al.  Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia , 2011, CNS drugs.

[15]  M. van den Buuse,et al.  Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice. , 2011, The international journal of neuropsychopharmacology.

[16]  A. Gogos,et al.  Differential effect of amphetamine on c-fos expression in female aromatase knockout (ArKO) mice compared to wildtype controls , 2011, Psychoneuroendocrinology.

[17]  A. Gogos,et al.  Estrogen Treatment Blocks 8-Hydroxy-2-dipropylaminotetralin- and Apomorphine-Induced Disruptions of Prepulse Inhibition: Involvement of Dopamine D1 or D2 or Serotonin 5-HT1A, 5-HT2A, or 5-HT7 Receptors , 2010, Journal of Pharmacology and Experimental Therapeutics.

[18]  A. Gogos,et al.  The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: An autoradiography study , 2010, Brain Research.

[19]  M. van den Buuse,et al.  Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. , 2009, The international journal of neuropsychopharmacology.

[20]  A. Gogos,et al.  Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters , 2009, Psychopharmacology.

[21]  A. Hannan,et al.  Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. , 2009, The international journal of neuropsychopharmacology.

[22]  M. Bailey,et al.  Estrogen in severe mental illness: a potential new treatment approach. , 2008, Archives of general psychiatry.

[23]  J. de Olmos,et al.  Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat , 2008, Brain Structure and Function.

[24]  J. T. Lightfoot,et al.  Sex Hormones' Regulation of Rodent Physical Activity: A Review , 2008, International journal of biological sciences.

[25]  M. Raiteri,et al.  N‐methyl‐D‐aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier‐mediated release of glutamate in rat hippocampus , 2007, Journal of neuroscience research.

[26]  A. Elias,et al.  Testosterone for schizophrenia. , 2007, The Cochrane database of systematic reviews.

[27]  I. Baconguis,et al.  N-Methyl-d-aspartate Receptor-dependent Regulation of the Glutamate Transporter Excitatory Amino Acid Carrier 1* , 2007, Journal of Biological Chemistry.

[28]  B. Larijani,et al.  Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia , 2006, Schizophrenia Research.

[29]  Sukanta Saha,et al.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology , 2004, BMC medicine.

[30]  A. Gogos,et al.  Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. , 2003, Behavioral neuroscience.

[31]  R. Kahn,et al.  Sex differences in the risk of schizophrenia: evidence from meta-analysis. , 2003, Archives of general psychiatry.

[32]  R. Harlan,et al.  Modulation of glutamate receptor expression by gonadal steroid hormones in the rat striatum , 2003, Brain Research Bulletin.

[33]  B. Dean,et al.  High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding , 2002, Journal of Neuroscience Methods.

[34]  M. Cyr,et al.  Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors , 2001, Brain Research Reviews.

[35]  P. Andiné,et al.  Characterization of MK-801-induced behavior as a putative rat model of psychosis. , 1999, The Journal of pharmacology and experimental therapeutics.

[36]  C. Mazure,et al.  Testosterone-patch-induced psychotic mania. , 1999, The American journal of psychiatry.

[37]  Paul J. Harrison.  Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics , 1999, British Journal of Psychiatry.

[38]  C. Tamminga.  Glutamatergic aspects of schizophrenia , 1999, British Journal of Psychiatry.

[39]  J. Krystal,et al.  The NMDA antagonist model for schizophrenia: promise and pitfalls. , 1998, Pharmacopsychiatry.

[40]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[41]  A. Beitz,et al.  Castration increases [125I]MK801 binding in the hippocampus of male rats , 1995, Brain Research.

[42]  D. Brann,et al.  Steroid hormone effects on NMDA receptor binding and NMDA receptor mRNA levels in the hypothalamus and cerebral cortex of the adult rat. , 1993, Neuroendocrinology.

[43]  Jon W. Johnson,et al.  Molecular bases of NMDA receptor subtype-dependent properties. , 2014, The Journal of physiology.

[44]  A. Gogos,et al.  Differential effects of estrogen and testosterone on auditory sensory gating in rats , 2013, Psychopharmacology.

[45]  Bita Moghaddam,et al.  From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment , 2012, Neuropsychopharmacology.

[46]  A. Gogos,et al.  The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia , 2011, Psychopharmacology.

[47]  M. van den Buuse.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. , 2010, Schizophrenia bulletin.

[48]  A. Gogos,et al.  Estrogen treatment blocks 8-OH-DPAT-and apomorphine-induced disruptions of prepulse inhibition : Involvement of dopamine D 1 or D 2 , serotonin 5-HT , 2009 .

[49]  Daniel C Javitt,et al.  Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. , 2007, International review of neurobiology.

[50]  R. Murray,et al.  Gender differences in schizophrenia: hormonal effect or subtypes? , 1995, Schizophrenia bulletin.

[51]  A. Beitz,et al.  Distribution of NMDAR1 receptor subunit mRNA and [125I]MK-801 binding in the hypothalamus of intact, castrate and castrate-DHTP treated male rats. , 1995, Brain research. Molecular brain research.

[52]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .